Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Kobayashi Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	56,288	50,873	71,536	96,233	95,024	78,253
Short-Term Investments	13,386	14,872	8,300	8,300	14,022	16,085
Cash & Short-Term Investments	69,674	65,745	79,836	104,533	109,046	94,338
Cash Growth	15.42%	-17.65%	-23.63%	-4.14%	15.59%	4.17%
Receivables	32,913	49,384	52,984	47,853	55,147	52,829
Inventory	30,653	24,163	22,081	17,678	15,107	14,139
Other Current Assets	2,731	5,176	3,430	2,828	2,589	2,919
Total Current Assets	135,971	144,468	158,331	172,892	181,889	164,225
Property, Plant & Equipment	73,447	67,448	47,665	34,778	22,524	20,821
Long-Term Investments	28,669	28,421	36,083	32,123	33,177	38,382
Goodwill	7,805	9,260	9,655	7,147	7,189	7,284
Other Intangible Assets	10,056	11,414	11,959	6,160	5,469	5,510
Long-Term Deferred Tax Assets	3,449	3,087	2,647	1,750	1,489	1,443
Other Long-Term Assets	2	1	1	2	1	1
Total Assets	260,710	265,368	267,473	255,827	252,554	238,366
Accounts Payable	15,407	14,688	17,305	18,056	17,444	15,926
Accrued Expenses	2,768	2,840	2,705	2,553	2,486	2,797
Short-Term Debt	-	-	-	-	1	13
Current Portion of Leases	355	343	379	261	169	170
Current Income Taxes Payable	18,412	19,376	29,884	25,317	25,662	26,756
Other Current Liabilities	9,563	9,176	5,838	5,622	4,941	4,445
Total Current Liabilities	46,505	46,423	56,111	51,809	50,703	50,107
Long-Term Leases	394	503	608	531	460	505
Long-Term Deferred Tax Liabilities	1,988	1,554	2,594	1,310	1,564	1,357
Other Long-Term Liabilities	2,546	2,413	2,405	2,244	2,209	1,855
Total Liabilities	52,469	51,898	62,657	57,928	56,955	55,784
Common Stock	3,450	3,450	3,450	3,450	3,450	3,450
Additional Paid-In Capital	522	522	522	522	4,183	4,183
Retained Earnings	207,022	208,240	205,681	194,285	200,534	187,071
Treasury Stock	-24,767	-24,767	-24,766	-14,482	-23,706	-19,763
Comprehensive Income & Other	22,014	26,021	19,929	14,124	11,138	7,641
Total Common Equity	208,241	213,466	204,816	197,899	195,599	182,582
Minority Interest	-	4	-	-	-	-
Shareholders' Equity	208,241	213,470	204,816	197,899	195,599	182,582
Total Liabilities & Equity	260,710	265,368	267,473	255,827	252,554	238,366
Total Debt	749	846	987	792	630	688
Net Cash (Debt)	68,925	64,899	78,849	103,741	108,416	93,650
Net Cash Growth	16.39%	-17.69%	-23.99%	-4.31%	15.77%	4.44%
Net Cash Per Share	927.18	873.03	1039.65	1344.98	1387.72	1198.14
Filing Date Shares Outstanding	74.34	74.34	74.34	76.13	77.28	78.16
Total Common Shares Outstanding	74.34	74.34	74.34	76.01	77.74	78.16
Working Capital	89,466	98,045	102,220	121,083	131,186	114,118
Book Value Per Share	2801.24	2871.53	2755.17	2603.46	2516.20	2335.91
Tangible Book Value	190,380	192,792	183,202	184,592	182,941	169,788
Tangible Book Value Per Share	2560.98	2593.42	2464.42	2428.40	2353.37	2172.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.